Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer

Clinical trial NCT00089297 · COMPLETED

Trial details

NCT number: NCT00089297
Sponsor: Eastern Cooperative Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2005-01-06
Primary completion: 2010-02-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.